FindTrial
Sign In

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-005031-96-ES
Enrollment
Unknown
Registered
2012-01-11
Start date
2012-02-27
Completion date
Unknown
Last updated
2012-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: TORISEL Pharmaceutical Form: Concentrate and diluent for solution for infusion INN or Proposed INN: TEMSIROLIMUS CAS Number: 162635-04-3 Concentration unit: mg milligram(s) Concentration t

Sponsors

Dr. Antonio Llombart Cussac
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 21 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 21

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Spain

Contacts

Public ContactDr. Antonio Llombart Cussac

Dr. Antonio Llombart Cussac

allombart1@yahoo.com0034963987 700

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026